Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Elevated Health vs Found

Two GLP-1 desks, one scoreboard. We put Elevated Health and Found head-to-head on the published Brief Score — the same six factors, scored the same way.

No. 416 · Grade C

Elevated Health

Visit Elevated Health Full brief →

FDA warning letter, September 2025 — issued to Elevate Your Wellness LLC, dba Elevated. See the FDA's warning letter database.

vs
Higher Brief ScoreNo. 33 · Grade B−

Found

Visit Found Full brief →

The verdict

Found takes this head-to-head.

Found scores 81 to 54 on our six-factor Brief Score — The widest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.

That doesn't make Elevated Health a bad call — it's best for readers who want affordable compounded glp-1 with oral option. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
48
84
Supply Reliability
67
88
Transparency
32
62
Access Breadth
62
92
Clinical Oversight
75
90
Track Record
41
86
Elevated HealthBrief Score 54 · 81Found

Price, coverage & the tracker

Elevated HealthFound
Brief Score54/100 (C)81/100 (B−)
SemaglutideFrom $296/mo (compounded)$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still sits before a ~$30 per-visit copay
TirzepatideFrom $359/mo (compounded)$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules
CoverageCoverage not publishedAll 50 states
Brand-name accessYesYes
Oral / sublingualYesYes
On the trackerNewnew to the tracker, no prior readingStableprice stable

Elevated Health: New to the tracker on 1 August 2026. The published line reads From $296/mo (compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Found: Headline unchanged, but our $129 line was wrong: the published floor is $99 and it requires a 3-, 6- or 12-month plan.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.